What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature

被引:104
作者
Bronsard, V. [1 ]
Paul, C. [2 ]
Prey, S. [2 ]
Puzenat, E. [3 ]
Gourraud, P-A [4 ,5 ,6 ]
Aractingi, S. [7 ,8 ]
Aubin, F. [3 ]
Bagot, M. [9 ]
Cribier, B. [10 ]
Joly, P. [11 ]
Jullien, D. [12 ]
Le Maitre, M.
Richard-Lallemand, M-A [13 ]
Ortonne, J-P [1 ]
机构
[1] Univ Nice, LArchet II Hosp, Dept Dermatol, Nice, France
[2] Univ Toulouse 3, Dept Dermatol, F-31062 Toulouse, France
[3] Univ Franche Comte, Dept Dermatol, F-25030 Besancon, France
[4] Toulouse Univ Hosp, Dept Epidemiol, Toulouse, France
[5] Fac Med Toulouse, INSERM, Unit 558, F-31073 Toulouse, France
[6] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[7] Tenon Hosp, APHP, Dept Dermatol, Paris, France
[8] Univ Paris 06, Paris, France
[9] Hop St Louis, Dept Dermatol, Paris, France
[10] Dept Dermatol, Strasbourg, France
[11] Univ Rouen, Rouen Univ Hosp, Dept Dermatol, F-76821 Mont St Aignan, France
[12] Hop Edouard Herriot, Dept Dermatol, Lyon, France
[13] Univ Mediterranee Aix Marseille 2, Dept Dermatol, Hop St Marguerite, Marseille, France
关键词
psoriasis; quality of life index; validity; INSTRUMENTS; SKINDEX; INDEX;
D O I
10.1111/j.1468-3083.2009.03563.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Background The assessment of health-related quality of life (QOL) is important in psoriasis. Despite this, among the wide variety of QOL questionnaires used in psoriasis, there is no consensus as to which is the best. Objective The objective of this systematic review was to identify which of these measurements have acceptable evaluation criteria for both monitoring disease and research purposes. We looked at validity, reliability, sensitivity to change (responsiveness) and acceptability, which are common criteria for any score and specific criteria for QOL questionnaire. Materials and Methods We performed a systematic review of all clinical studies investigating the QOL of psoriasis patients, published between January 1988 and June 2009. Results Twenty-one QOL questionnaires were identified. Eight of these satisfied most of the validation criteria; they were multidimensional and had been used in clinical research: short form 36 (SF 36), Dermatology Life Quality Index (DLQI), Skindex 29, Skindex 17, Dermatology Quality of life Scale (DQOLS), Psoriasis Disability Index (PDI) Impact of Psoriasis Questionnaire (IPSO) and Psoriasis Index of Quality of Life (PSORIQOL). Construct validity, content validity and internal consistency were adequately assessed and good performance was achieved for all questionnaires. Reproducibility (undetermined for Skindex 17) and acceptability were good for all questionnaires. Sensitivity to change was determined good for the SF36, DLQI, Skindex 29 and PDI. Item bias, unidimensional structure and cross-cultural equivalence were poor for all but the Skindex 17 and SF36 questionnaires. Conclusion On the basis of this systematic review, we can conclude that the DLQI is easy to use in clinical practice because of its brevity and simplicity. SF36 is widely used in clinical trials. Skindex 29 and Skindex 17, although rarely used, are interesting because of their cross-cultural validation.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 17 条
[1]
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results [J].
Basra, M. K. A. ;
Fenech, R. ;
Gatt, R. M. ;
Salek, M. S. ;
Finlay, A. Y. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) :997-1035
[2]
Critical review of generic and dermatology-specific health-related quality of life instruments [J].
Both, Hilde ;
Essink-Bot, Marie-Louise ;
Busschbach, Jan ;
Nijsten, Tamar .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (12) :2726-2739
[3]
Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness [J].
Chren, MM ;
Lasek, RJ ;
Quinn, LM ;
Mostow, EN ;
Zyzanski, SJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (05) :707-713
[4]
Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme [J].
de Korte, J ;
Van Onselen, J ;
Kownacki, S ;
Sprangers, MAG ;
Bost, JD .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (01) :35-41
[5]
Quality of life in patients with psoriasis: A systematic literature review [J].
de Korte, J ;
Sprangers, MAG ;
Mombers, FMC ;
Bos, JD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (02) :140-147
[6]
Determinants of quality of life in patients with psoriasis: A study from the US population [J].
Gelfand, JM ;
Feldman, SR ;
Stern, RS ;
Thomas, J ;
Rolstad, T ;
Margolis, DJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) :704-708
[7]
Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? [J].
Grob, Jean Jacques .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (10) :2299-2301
[8]
Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice [J].
Guyatt, Gordon H. ;
Ferrans, Carol Estwing ;
Halyard, Michele Y. ;
Revicki, Dennis A. ;
Symonds, Tara L. ;
Varricchio, Claudette G. ;
Kotzeva, Anna ;
Valderas, Jose M. ;
Alonso, Jordi L. .
MAYO CLINIC PROCEEDINGS, 2007, 82 (10) :1229-1239
[9]
Translating the science of quality of life into practice: What do dermatology life quality index scores mean? [J].
Hongbo, Y ;
Thomas, CL ;
Harrison, MA ;
Salek, MS ;
Finlay, AY .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (04) :659-664
[10]
Leplège A, 2003, ANN DERMATOL VENER, V130, P177